SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,636.32 -487.51
( -0.67%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

501.202063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

17.42

15540.43

EPS(TTM)

Face Value()

Div & Yield %

45.47

0.58

Back

Indiamart Intermesh consolidated net profit rises 12.18% in the June 2026 quarter

Jul 21,2026

Net profit of Indiamart Intermesh rose 12.18% to Rs 172.20 crore in the quarter ended June 2026 as against Rs 153.50 crore during the previous quarter ended June 2025. Sales rose 11.37% to Rs 414.40 crore in the quarter ended June 2026 as against Rs 372.10 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	414.40	372.10	11
OPM %	31.83	32.09	-
PBDT	238.10	210.80	13
PBT	231.70	203.90	14
NP	172.20	153.50	12

72,636.32 -487.51 ( -0.67%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)